8. SLEEP

Published on 09/04/2015 by admin

Filed under Hematology, Oncology and Palliative Medicine

Last modified 09/04/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2339 times

CHAPTER 8. SLEEP
Catherine Vena
Sleep is an essential human need and an important component of human homeostasis. Despite an explosion of scientific discovery about sleep in the past 50 years, there is much to be discovered about the role of sleep in health and illness. However, research has shown that the lack of adequate sleep results in poor physical and mental function (Pilcher & Huffcutt, 1996). Because sleep has also been found to be important for immune, endocrine, and metabolic functions, insufficient or poorly timed sleep affects health and well-being (Akerstedt & Nilsson, 2003). Yet sleep problems are common in chronic illnesses such as cancer (Clark, Cunningham, McMillan, et al., 2004; Vena, Parker, Cunningham et al., 2004), cardiopulmonary disease (Gay, 2004; Parker & Dunbar, 2002), and neurological disorders such as Parkinson’s disease (Rye, 2004) and Alzheimer’s disease (Ancoli-Israel, Gehrman, Martin et al., 2003). Furthermore, sleep is frequently disturbed in populations characterized by chronic pain (Landis, Frey, Lentz et al., 2003) and is often associated with psychosocial distress such as anxiety, depression, or worry (Bixler, Vgontzas, Lin et al., 2002; Hall, Buysse, Nowell et al., 2000; Morin, Rodrigue, & Ivers, 2003). For the person experiencing a chronic or life-threatening illness, disturbed sleep has important implications for clinical outcomes. The sleep of family members, especially those who are caregivers for the chronically and terminally ill, is also at risk for being disrupted or inadequate due to either the patient’s sleep problems or the burdens of caregiving, which places the family unit at risk for adverse outcomes (Carter, 2002, 2003). Therefore, it is important that advanced practice nurses (APNs) be proactive in assessing and promoting sleep in their palliative care practice. This chapter reviews normal sleep and sleep regulation, discusses factors that lead to disturbed sleep, and presents evidence-based interventions to promote sleep.

OVERVIEW OF NORMAL SLEEP

Despite the fact that a third of human existence is spent in the sleep state, there is little understanding of why sleep is needed or what mechanisms underlie its capacities for physical and mental restoration. As late as the early twentieth century, sleep was believed to be a passive, quiescent state intermediate between wakefulness and death. However, the discovery of rapid eye movement (REM) and the identification of the dramatic effects of sleep deprivation in the mid-twentieth century prompted an escalation in research concerning the physiology, neurobiology, and biobehavioral aspects of sleep (Akerstedt & Nilsson, 2003). It is now known that sleep is an active process characterized by a distinct architecture and rhythmicity. There are actually three discrete, functional states of the brain: waking, non-REM (NREM) sleep, and REM sleep. The cycling of these states is at two levels: the basic wake/sleep cycle and the within-sleep cycle of REM and NREM sleep. A complex array of behavioral, neuroendocrine, and central nervous system factors regulates these cycles. In optimal conditions, waking is consolidated during the day and sleeping is consolidated at night. In the presence of pathology or physical illness, it is possible to see intrusion of wakefulness into the sleeping period and, conversely, intrusion of sleep into the wake period.
Normal sleep consists of a sequence of various stages distinguished by electroencephalographic (EEG) activity, muscle tone, and eye movements (Silber, Krahn, & Morgenthaler, 2004). Sleep is initiated after an initial stage of drowsiness. The first stage, NREM sleep, is divided into stages 1 through 4, roughly corresponding to sleep depth. Each stage has its own “signature” of EEG activity. Stage 1 is characterized by mixed-frequency low-amplitude waves; stage 2 is characterized by K complexes and spindles; and stages 3 and 4 are characterized by progressively greater numbers of slow, high-amplitude waves. Stages 3 and 4 are also collectively termed slow-wave sleep (SWS) and are associated with the highest arousal threshold. REM sleep is characterized by EEG activity somewhat similar to stage 1 or wakefulness and by episodic bursts of eye movements and a loss of muscle tone. While often associated with dreaming, it is now known that dreaming can also occur during NREM sleep. Normal sleep architecture across the night consists of NREM alternating with REM sleep in approximately 90- to 120-minute cycles. A young adult will typically have four to six of these cycles as illustrated in Figure 8-1. Most SWS generally occurs during the first half of the night, while more REM sleep occurs during the second half. Stage 1 sleep represents 2% to 5% of total sleep; stage 2, 45% to 55%; and stages 3 and 4, about 13% to 23%. Typically, REM sleep accounts for 20% to 25% of total sleep (Carskadon & Dement, 2005). Brief arousals punctuate normal sleep, although only the longest of these are remembered. Arousals tend to increase in frequency as sleep quality deteriorates. Common terms used in conjunction with sleep are listed in Box 8-1.
B9781416030799500166/f08-01-9781416030799.jpg is missing
Figure 8-1

Box 8-1

Apnea Cessation of airflow at the nostrils and mouth lasting at least 10 seconds.
Arousal Abrupt change from sleep to wakefulness, from a “deeper” stage of non-REM sleep to a “lighter” stage.
Circadian rhythm Innate, daily fluctuation of behavioral and physiological functions, including sleeping and waking, generally tied to the 24-hour day-night cycle but sometimes to a different (e.g., 23- or 25-hour) periodicity when light/dark and other time cues are removed.
Excessive daytime sleepiness Difficulty in maintaining the alert, awake state.
Insomnia Sleep problems characterized by difficulty falling asleep, frequent awakenings during the night, or waking up earlier than desired that can result in getting up in the morning feeling nonrested and experiencing drowsiness during the day. Insomnia may be primary or secondary to other conditions.
K complex Sharp, negative, high-voltage EEG wave, followed by a slower, positive component. K complexes occur spontaneously during NREM sleep and define stage 2.
Light sleep Term used to describe non-REM sleep stage 1 and sometimes stage 2.
NREM sleep Non–rapid eye movement sleep; divided into four stages, 1 through 4. A stage of sleep in which brain activity and bodily functions slow down. NREM sleep accounts for the largest portion of the sleep cycle.
Periodic limb movement disorder Disorder characterized by periodic episodes of repetitive and highly stereotyped limb movements that occur during sleep.
Polysomnogram (PSG) Gold standard for objective measurement of sleep. PSG involves the continuous and simultaneous recording of physiological variables during sleep, i.e., EEG, EOG, EMG (the three basic stage scoring parameters), ECG, respiratory air flow, respiratory excursion, lower limb movement, and other electrophysiological variables.
REM density Function that expresses the frequency of eye movements per unit of time during REM sleep.
REM sleep Rapid eye movement sleep. REM sleep occurs in brief spurts of increased activity in the brain and body. REM is considered the dreaming stage of sleep. It is characterized by the darting of the eyes under the eyelids.
Restless legs syndrome (RLS) Disorder characterized by sensations in the legs that tend to occur when an individual is not moving and are usually worse in the evening. There is an almost irresistible urge to move the legs; the sensations are relieved by movement.
Sleep apnea syndrome Disorder characterized by repetitive episodes of reduced or absent respiratory airflow that occur during sleep and that are usually associated with a reduction in blood oxygen level. Symptoms include loud snoring and a gasping or snorting sound when the sleeping individual starts to breathe again. Although the individual may not be aware of having sleep apnea, the condition can disrupt the quality of sleep and result in daytime fatigue. The most common type, obstructive sleep apnea, occurs when the tongue or other soft tissue blocks the airway.
Sleep architecture NREM-REM sleep-stage and cycles.
Sleep debt Result of recurrent sleep deprivation that occurs over time when an individual does not experience a sufficient amount of the restorative daily sleep that is required to maintain a sense of feeling rested and refreshed.
Sleep deprivation Acute or chronic lack of sufficient sleep.
Sleep diary (log) Daily, written record of an individual’s sleep-wake pattern containing such information as time of retiring and arising, time in bed, estimated total sleep period, number and duration of sleep interruptions, quality of sleep, daytime naps, use of medications or caffeine beverages, nature of waking activities, and other data.
Sleep disorders Broad range of illnesses arising from many causes, including dysfunctional sleep mechanisms, abnormalities in physiological functions during sleep, abnormalities of the biological clock, and sleep disturbances that are induced by factors extrinsic to the sleep process.
Sleep efficiency (SE) Proportion of sleep in the episode filled by sleep; the ratio of TST to time in bed.
Sleep fragmentation Brief arousals occurring throughout the night, reducing the total amount of time spent in the deeper levels of sleep.
Sleep latency (SL) Time period measured from “lights out,” or bedtime, to the beginning of sleep.
Sleep onset Transition from wake to sleep, normally into NREM stage 1.
Sleep pattern (24-hour sleep-wake pattern) Individual’s clock hour schedule of bedtimes and rise times as well as nap behavior: may also include time and duration of sleep interruptions.
Slow-wave sleep (SWS) Common term for NREM stages 3 and 4 (also called delta or deep sleep).
Total sleep time (TST) Amount of actual sleep time in a sleep episode; the time is equal to the total sleep episode less the awake time.
Zeitgeber Environmental time cue that entrains biological rhythms to a specific periodicity. Known Zeitgebers are light, melatonin, and physical activity.
Data from Kryger, M.H., Roth, T., & Dement, W.C. (Eds.). (2005) Principles and practice of sleep medicine (4th ed.). Philadelphia: Elsevier Saunders; American Academy of Sleep Medicine (2005). The international classification of sleep disorders: Diagnostic and coding manual, ICSD-2 (2nd ed.). Westchester, Ill: Author; and Silber, M.H., Krahn, L.E., & Morgenthaler, T.I. (2004). Sleep medicine in clinical practice, London: Taylor & Francis.
Normal aging plays a role in changes in sleep, but there is also evidence that psychosocial factors and medical illness may be significant contributors to disturbed sleep in the elderly. In a large survey, elders’ sleep complaints were associated with respiratory symptoms, physical disability, depressive symptoms, and poor perceived health (Foley, Monjan, Brown et al., 1995). Other studies have demonstrated that in the absence of psychological, medical, and social factors that affect sleep, sleep problems in elders were much less frequent or even nonexistent (Bliwise, King, Harris et al., 1992; Ford & Kamerow, 1989; Gislason & Almqvist, 1987; Vitiello, Moe, & Prinz, 2002).

The Function of Sleep

While the exact function of sleep remains unclear, there are a number of theories. Some have suggested that sleep, especially NREM sleep, is necessary to reverse and/or restore biochemical and/or physiological processes through protein synthesis, cell division, and growth. Others have postulated that sleep serves to conserve energy through reduced metabolic rate and body temperature (Silber et al., 2004). There have also been numerous speculations on the functions of REM sleep, including brain restoration, consolidation of memory, and erasure of inappropriate memories (Siegel, 2001). Sleep also appears to be important for immune and endocrine function, metabolism, and thermoregulation (Krueger, Majde, & Obal, 2003; McGinty, Alam, Szymusiak et al., 2001; Steiger, 2003; Van Someren, 2000). None of these theories is supported unequivocally by current evidence. Most likely, sleep serves many functions.

Sleep Regulation

A basic understanding of the mechanisms that regulate sleep is necessary to appreciate how the sleep-wake cycle may be disrupted in palliative care patients. Two basic processes govern physiological sleepiness and wakefulness: process S and process C (Borbely, 1982). Process S is the homeostatic pressure to sleep that increases with the length of time an individual is awake and is eliminated by sleep. Process C, the circadian rhythm, is regulated by a clocklike mechanism in the brain (located in the suprachiasmatic nucleus). Process C represents the drive for wakefulness that is lowest in the early morning hours and highest at mid-day. The natural sleep-wake rhythm cycle is about 25 hours. However, cues from the environment (zeitgebers) entrain or “set” sleep’s rhythm to a 24-hour schedule. As a result, humans depend on external cues such as exposure to light, regular meals, and social interactions to keep their diurnal cycle “on time.”
Sleep propensity, sleep structure, and waking are regulated by a subtle and complex interaction of the two processes. Process C serves to maintain sleep as process S declines during the night and to maintain alertness as process S increases during the day (Borbely & Achermann, 2005). NREM sleep intensity is determined primarily by the homeostatic process (process S), and REM sleep by the circadian process (process C), while the ratio of REM to NREM sleep depends on both homeostatic and circadian factors. Factors that either interfere with or support these processes have the potential to significantly affect the timing, duration, and structure of sleep as well as daytime functioning.

EFFECTS OF IMPAIRED SLEEP

Impaired sleep may be the result of an inadequate amount of sleep or frequent disruption or fragmentation of sleep. The amount of sleep each person needs depends on many factors, including age. For most adults, 7 to 8 hours a night appears to be the best amount of sleep, although some people may need as few as 5 hours or as many as 10 hours of sleep each day (National Institute of Neurological Disorders and Stroke, 2005). The most common causes for inadequate amounts of sleep are self-imposed sleep restriction or lifestyle or work demands that require staying awake at night (Lee, Landis, Chasens et al., 2004). Caregivers are especially at risk for this type of sleep loss (Carter, 2002, 2003). Getting too little sleep creates a “sleep debt,” which eventually demands repayment. Contrary to popular belief, humans do not adapt to getting less sleep than needed. Although individuals may become accustomed to a sleep-depriving schedule, adverse effects remain apparent. Sleep fragmentation can occur because of environmental conditions, but it is frequently the consequence of acute or chronic illness or primary sleep disorders. Both inadequate amounts of sleep and frequently interrupted sleep result in sleep loss, a condition with known adverse consequences. In addition to daytime sleepiness, sleep loss has been shown to produce impairment in cognitive function, including reduced attention, short-term memory, and problem-solving ability (Bonnet, 2005). Sleep fragmentation can also result in elevation of blood pressure, increases in urinary and serum catecholamines (an indicator of acute stress), arrhythmias, and progression of heart failure (Leung & Bradley, 2001; Sin, Logan, Fitzgerald et al., 2000). In addition, sleep loss has been shown to produce a catabolic state leading to negative nitrogen balance, alter immune function, increase oxygen consumption and carbon dioxide production, and disrupt thermoregulation (Bonnet, 2005). Thus, the lack of consolidated, restorative sleep places the palliative care patient and their caregivers at risk for adverse outcomes.

Factors Contributing to Disturbed Sleep in the Palliative Care Setting

Disturbed sleeping and waking are usually multifactoral. Some factors such as a history of primary sleep disorder and demographic or lifestyle factors predispose the patient to further problems with sleep when confronted with a chronic or life-threatening illness. Other factors, such as psychosocial, disease-related, and treatment-related factors, precipitate sleep-wake disturbance through further interference with sleep regulatory processes (process S and process C).

PRIMARY SLEEP DISORDERS

From population-based surveys, the National Sleep Foundation (NSF) estimates that at least 34% of Americans are at risk for primary sleep disorders such as insomnia, sleep apnea, and restless legs syndrome (NSF, 2005a). This means that tens of millions of Americans have undiagnosed and untreated sleep disorders. In addition, the average amount of sleep obtained by adults in this country is 6.9 hours per weeknight. Seventy-one percent of adults say they sleep less than 8 hours per night; 40% report sleeping less than 7 hours (NSF, 2005a). Thus, a significant number of patients seen in a palliative care practice may have a preexisting sleep disorder or chronic sleep deprivation, conditions that could worsen the effect of numerous precipitating factors associated with their disease process or treatments.

Demographic Factors

Researchers have identified increased reports of sleep problems in people who are older, female, single, and of lower socioeconomic status (Bliwise, 2005; Breslau, Roth, Rosenthal et al., 1997; Moore, Adler, Williams et al., 2002; Steptoe & Marmot, 2003). Of these factors, age appears to have the most significant impact on sleep. Elders have increased fragmentation of sleep, decreased amounts of deep sleep, and increased daytime napping that are linked to age-related changes that alter both homeostatic (process S) and circadian (process C) cycles, including (1) nocturia, (2) elevated autonomic activity that results in a greater susceptibility to arousal, and (3) decreased strength of circadian rhythms (Bliwise, 2005). Furthermore, primary sleep disorders such as sleep apnea (Young, Skatrud, & Peppard, 2004), periodic limb movements during sleep (Montplaisir, Allen, Walters et al., 2005), and insomnia are more prevalent in the elderly (Benca, Ancoli-Israel, & Moldofsky, 2004). While older men have more objective changes in sleep architecture, older women are more likely to complain of sleep difficulties (Rediehs, Reis, & Creason, 1990). Thus, elders in the palliative care setting may be at greater risk for disturbed sleep.

Lifestyle Factors

Lifestyle behaviors can influence quantity and quality of sleep (Lee-Chiong, 2002). Two factors that can interfere with both process S and process C are (1) the timing and duration of sleep periods and (2) conditions or agents that cause arousal in the sleep setting. Because the homeostatic drive for sleep is influenced by the amount of prior sleeping or waking, long naps taken during the daytime hours, especially late in the day, decrease the drive to sleep during the nocturnal sleep period (Monk, Buysse, Carrier et al., 2001). In addition, irregular bedtimes, staying longer in bed, and decreased daytime activity interfere with circadian activity-rest patterns (Lee-Chiong, 2002). Maintaining regular bed and rise times, as well as regular daily activity, enhances nocturnal sleep. Environmental factors and ingestion of common substances can interfere with process S by eliciting arousal. Room temperature, noise, and light level, as well as use of stimulants (such as caffeine in coffee and soft drinks and nicotine in tobacco products), can interfere with sleep onset or sleep continuity. Although alcohol ingestion is generally associated with sedation, falling blood alcohol levels produce sympathetic arousal so that sleep continuity after ingestion becomes a problem (Gillin, Drummond, Clark et al., 2005). These behaviors or conditions in combination can produce a profound effect on sleep.

Psychosocial Factors

Anxiety and depression are commonly encountered in palliative care practices. Researchers have found that anxiety related to a general stress burden is associated with numerous changes in sleep architecture, including a reduced amount of total sleep time, difficulty getting to sleep, reduced SWS, increased microarousals and stage 1 sleep, and reduced REM density (Hall et al., 2000; Kecklund & Akerstedt, 2004). These findings suggest that anxiety can interfere with process S by causing increased physiological arousal. Disturbed sleep is also a key feature of depression. Sleep in persons diagnosed with major depression and dysthymia is characterized by changes in sleep architecture including decreased SWS, reduced REM latency, prolonged first REM period, and higher REM density (total eye movements/total REM time), as well as by sleep continuity disturbances and excessive daytime sleepiness (Benca, 2005). It has been hypothesized that these changes in sleep architecture may be due to deficiencies in process S (Borbely & Wirz-Justice, 1983) and changes in the circadian rhythm of body temperature (Avery, Wildschiodtz, Smallwood et al., 1986; Schultz & Lund, 1983). However, the role of depression and anxiety in sleep disturbance is not always clear. Increasing data indicate that sleep problems often precede clinical depression and anxiety (Breslau, Roth, Rosenthal et al., 1996; Ohayon & Roth, 2003).

Disease-Related Factors Chronic Illness

Many persons with chronic illnesses, including cardiac diseases, lung diseases, renal failure, and cancer, report sleep problems (Parker, Bliwise, & Rye, 2000; Parker & Dunbar, 2002; Serber, Sears, Sotile et al., 2003; Silber et al., 2004; Vena et al., 2004). Common complaints among patients with these conditions include difficulty getting to sleep, frequent interruptions in sleep, daytime sleepiness, and fatigue. These complaints are likely the result of the disease process or treatments that have the potential to disturb sleep regulatory processes.

Pain

Disturbed sleep is a key complaint of patients experiencing both acute and chronic pain (Roehrs & Roth, 2005). Researchers have discovered that areas in the brain that process pain signals also regulate NREM sleep. This phenomenon may at least partially explain the interaction between pain and poor sleep (Basbaum & Jessell, 2000). Persons with pain have reduced amounts of SWS and often experience fragmented sleep related to the arousing property of pain (Lavigne, Zucconi, Castronovo et al., 2000). These findings suggest alterations in process S.
Sleep loss can also affect pain perception. Persons deprived of SWS or undergoing a cumulative sleep deficit (33% reduction in habitual amount) demonstrate a lowered pain threshold and increased somatic complaints (headache, sore joints) (Dinges, Pack, Williams et al., 1997; Lentz, Landis, Rothermel et al., 1999). Conversely, a good night of sleep may enhance mood and coping with pain. One group of investigators found that sleep quality was more likely to predict the following day’s mood and physical symptoms than were mood and symptoms able to predict the following night’s sleep quality (Totterdell, Reynolds, Parkinson et al., 1994).

Fatigue

Fatigue is a prevalent and disruptive symptom of many chronic illnesses, including heart failure, chronic lung disease, and cancer (Ancoli-Israel et al., 2003; Nordgren & Sorensen, 2003; Reishtein, 2005). There are many potential causes of fatigue in chronic illness, including preexisting physical conditioning, physical and psychological symptoms, and the consequences of treatments (Sharpe & Wilks, 2002). Several studies have demonstrated a link between fatigue and nocturnal sleep disturbance (Ancoli-Israel et al., 2003; Reishtein, 2005). Fatigue can lead to inactivity and daytime napping which interferes with process S. In turn, inactivity can also lead to a disruption in circadian activity/rest cycles (process C). Daytime sleepiness and “feeling drowsy” have also been identified as factors in the perceived level of fatigue (Ahsberg & Furst, 2001; Hwang, Chang, Rue et al., 2003). One study found that patients use the terms “lack of energy,” “tiredness,” and “fatigue” rather that “sleepiness” to describe their problem (Chervin, 2000). It may be that both patients and clinicians operationalize daytime sleepiness and fatigue in ways that contribute to confusing rather than distinguishing between the conditions (Pigeon, Sateia, & Ferguson, 2003).

Other Symptoms

Palliative care patients are likely to present with a number of other symptoms that interfere with sleep, including dyspnea, cough, nausea, gastrointestinal disturbances, and/or hot flashes (Albert, Davis, & Young, 2002; Blackler, Mooney, & Jones, 2004; Sachs, Shega, & Cox-Hayley, 2004; Walsh, Donnelly, & Rybicki, 2000). Although there is little research into the interaction of common nonpain symptoms and sleep, physical discomfort can delay onset of sleep or interrupt sleep (process S). The APN needs to carefully assess for the presence of these symptoms and their impact on sleep.

Treatment-Related Factors

It is becoming increasingly apparent that medical treatments have the potential to interfere with sleep regulatory processes and thus precipitate sleep loss. Sleep disturbances have been associated with hospitalization (Carvalhaes-Neto, Ramos, Suchecki et al., 2003; Redeker, 2000), surgery and anesthesia (Cronin, Kiefer, Davies et al., 2001; Redeker, Ruggiero, & Hedges, 2004; Rosenberg-Adamsen, Skarbye, Wildschiodtz et al., 1996), cancer therapies (Berger & Higginbotham, 2000; Capuron, Ravaud, & Dantzer, 2000; Miaskowski & Lee, 1999; Stein, Jacobsen, Hann et al., 2000), and hemodialysis (Parker et al., 2000). In addition, most palliative care patients received a number of medications to control the disease process or alleviate associated symptoms. A number of these may interfere with sleep or wakefulness. Impaired renal, hepatic, or neurological function in the chronically ill can further sensitize patients to adverse effects from their medications. It is beyond the scope of this chapter to provide a comprehensive review of the effect of medications on the sleep-wake cycle. However, the major types of drugs known to effect sleep and wakefulness are summarized in Table 8-1

Buy Membership for Hematology, Oncology and Palliative Medicine Category to continue reading. Learn more here